13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q2 2025 · Filed July 10, 2025 · Accession 0000950123-25-006247
Total Value
$15.9M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Kyverna Therapeutics, Inc. | KYTX | 4,523,924 | $13.9M | 87.24% |
| 2 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $2.0M | 12.76% |